Session Details
[GS05]Nothing seek, nothing find. --Where is molecular imaging heading?--
Mon. Mar 29, 2021 1:15 PM - 3:15 PM JST
Mon. Mar 29, 2021 4:15 AM - 6:15 AM UTC
Mon. Mar 29, 2021 4:15 AM - 6:15 AM UTC
[Room E] Oral Presentation E Online
Organizer: Nakajima Kohei (Grad. Sch. Pharm. Sci., Hokkaido Univ.), Kaide Sho (Grad. Sch. Pharm. Sci., Kyoto Univ.)
Molecular imaging is a technique to visualize, characterize and quantify in vivo biological processes of biomolecules such as proteins. For example, SPECT and PET have long been used in both basic and clinical studies for analysis of human body and diagnosis. In addition, new techniques including fluorescence imaging and photoacoustic imaging have advanced over the past 20 years in the field of molecular imaging. And recently, the concept of theranostics which integrates diagnosis (imaging) and therapeutics has emerged.
In this symposium, researchers at the forefront will present the current state of research in molecular imaging methods using fluorescence, photoacoustic waves, and ionizing radiation, and in photo-/radio-theranostics. Also, the symposiasts will introduce their research for developing diagnostic and/or therapeutic methods and understanding biological processes in the human body. We hope that contemplating the future trends in the field of molecular imaging at this opportunity will lead to a variety of the future in the coming decades.
In this symposium, researchers at the forefront will present the current state of research in molecular imaging methods using fluorescence, photoacoustic waves, and ionizing radiation, and in photo-/radio-theranostics. Also, the symposiasts will introduce their research for developing diagnostic and/or therapeutic methods and understanding biological processes in the human body. We hope that contemplating the future trends in the field of molecular imaging at this opportunity will lead to a variety of the future in the coming decades.
挨拶・趣旨説明：中島 孝平（北大院薬）
[GS05-1]Identification and utilization of α-mannosidase 2C1 as a biomarker enzyme for rapid clinical fluorescence imaging of breast tumors
○Kyohhei Fujita1, Mako Kamiya1,3, Hiroaki Ueo4, Yasuteru Urano1,2,5 (1. Grad. Sch. Med., Univ. Tokyo, 2. Grad. Sch. Pharm. Sci., Univ. Tokyo, 3. JST-PRESTO, 4. Ueo Breast Cancer Hospital, 5. AMED-CREST)
[GS05-2]Development of functional cyanine dyes for photoacoustic imaging
○Koki Tsuchiya1, Hideo Takakura1, Mikako Ogawa1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[GS05-3]Application of molecular imaging for photoimmunotherapy
○Kohei Nakajima1, Hideo Takakura1, Mikako Ogawa1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[GS05-4]Development of nuclear medicine imaging technique targeting brain protein aggregates in neurodegenerative disease
○Sho Kaide1, Hiroyuki Watanabe1, Shimpei Iikuni1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[GS05-5]Development of probes for theranostics with tumor-targeting peptides
○Hiroaki Echigo1, Kenji Mishiro2, Saki Hirata1, Koushin Washiyama3, Kazuhiro Takahashi3, Kazuhiro Shiba4, Seigo Kinuya1, Kazuma Ogawa1,2 (1. Grad. Sch. Med. Sci., Kanazawa Univ., 2. InFiniti., Kanazawa Univ., 3. Fukushima Med. Univ., 4. Adv. Sci., Kanazawa Univ.)
[GS05-6]Development of scaffolds for radiotheranostics with heavy halogens
○Yuta Kaizuka1, Hiroyuki Suzuki1, Tomoya Uehara1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)